首页> 外国专利> METHOD TO USE A STABLE FOAM COMPOSED OF BUBBLES OF VARIOUS FOOD/SUPPLEMENT/COSMETIC/PHARMACEUTICAL SUBSTANCES TO INCREASE THE BIO-AVAILABILITY OF OTHERWISE INERT MOLECULAR HYDROGEN GAS FOR MEDICALLY USEFUL HEALTH MAINTENANCE, HEALTH PROMOTION, ANTI-AGING AND GENERALIZED DISEASE PROCESS INTERFERENCE PURPOSES IN BIOLOGICAL LIVING SYSTEMS IN A MANNER WHICH...

METHOD TO USE A STABLE FOAM COMPOSED OF BUBBLES OF VARIOUS FOOD/SUPPLEMENT/COSMETIC/PHARMACEUTICAL SUBSTANCES TO INCREASE THE BIO-AVAILABILITY OF OTHERWISE INERT MOLECULAR HYDROGEN GAS FOR MEDICALLY USEFUL HEALTH MAINTENANCE, HEALTH PROMOTION, ANTI-AGING AND GENERALIZED DISEASE PROCESS INTERFERENCE PURPOSES IN BIOLOGICAL LIVING SYSTEMS IN A MANNER WHICH...

机译:方法一起使用稳定的泡沫各种食品/品/化妆品/药用物质气泡构成,以增加生物利用惰性的氢气分子FOR医学上有用的健康维护,健康促进,抗老化和广义疾病过程干扰目的,作者……的生物生活系统

摘要

This invention embodies a method to increase bioavailabilty of molecularhydrogen toboth external and internal tissue surfaces including but not limited toepidermisexternal (e.g. skin) and epidermis internal (e.g. intraocular, vulvar, vaginaland internalreproductive structures, mouth, throat, esophegus , stomach , duodenum andcolon).secondary bioavailablity via extended assimilation e.g. via the lung as aresult of slowrelease of hydrogen from bubbles in the stomach which are aspirated into thelung is aderivative of the primary use of this invention and therefore an aspect of it.Another embodiment is the use of this invention to make molecular hydrogenavailablein a delivery medium which does not carry with it the regulatory impedimentsandinsurance and safety of use liabilities as found in the state of the art whichis freemolecular hydrogen in uncompressed free gas or hyperbaric compressed gasstate.The state of the art is also restricted by the homeopathic concentrationsavailable in"hydrogen water" or a limited use as an "in situ" derivative of lactulosewithin thebowel. This invention provides a solution to these problems.
机译:本发明体现了增加分子生物利用度的方法氢成内部和外部组织表面都包括但不限于表皮外部(例如皮肤)和表皮内部(例如眼内,外阴,阴道和内部生殖结构,嘴,喉,食道,胃,十二指肠和结肠)。通过延长的同化作用产生的二次生物利用度通过肺慢的结果从胃中的气泡中释放出氢气,这些气泡被吸入胃中肺是本发明主要用途的派生衍生物,因此是本发明的一个方面。另一个实施方案是本发明用于制备分子氢的用途有空在不带有监管障碍的传送介质中和现有技术中发现的保险和使用安全责任免费未压缩自由气体或高压压缩气体中的分子氢州。顺势疗法浓度也限制了现有技术水平可在“氢水”或乳果糖的“原位”衍生物的有限用途在肠。本发明提供了针对这些问题的解决方案。

著录项

  • 公开/公告号CA2821870A1

    专利类型

  • 公开/公告日2015-01-26

    原文格式PDF

  • 申请/专利权人 JOHNSON MORRIS FOLKE;

    申请/专利号CA20132821870

  • 发明设计人 JOHNSON MORRIS FOLKE;

    申请日2013-07-26

  • 分类号A61K9/10;A61K8/19;A61K33;A61Q19/08;

  • 国家 CA

  • 入库时间 2022-08-21 15:11:27

相似文献

  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号